Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Faron Pharma Share Price
  4. Faron Pharma Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksFaron Pharma Share News (FARN)

Faron Pharma Information

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 238.00
Bid: 230.00
Ask: 246.00
Change: 0.00 (0.00%)
Spread: 16.00 (6.957%)
Open: 238.00
High: 238.00
Low: 238.00
Prev. Close: 238.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th Mar 2021 16:06

Friday 19 March 
Sanne Group PLCFull Year Results
Investec PLCTrading Statement
Johnson Service Group PLCFull Year Results
JD Wetherspoon PLCHalf Year Results
ContourGlobal PLCFull Year Results
Monday 22 March 
Blackbird PLCFull Year Results
Yew Grove REIT PLCFull Year Results
Centamin PLCFull Year Results
Kingfisher PLCFull Year Results
SDX Energy PLCFull Year Results
Tuesday 23 March 
accesso Technology Group PLCFull Year Results
Alliance Pharma PLCFull Year Results
Arrow Global Group PLCFull Year Results
Cambridge Cognition PLCFull Year Results
DP Eurasia NVFull Year Results
Elementis PLCFull Year Results
Energean PLCFull Year Results
essensys PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
H&T Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Longboat Energy PLCFull Year Results
LoopUp Group PLCFull Year Results
Luceco PLCFull Year Results
Malin Corp PLCFull Year Results
McColl's Retail Group PLCFull Year Results
MJ Hudson Group PLCHalf Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
MP Evans Group PLCFull Year Results
Old Mututal LtdFull Year Results
Personal Group Holdings PLCFull Year Results
YouGov PLCFull Year Results
Zotefoams PLCFull Year Results
Wednesday 24 March 
Softcat PLCHalf Year Results
Circassia Group PLCFull Year Results
Burford Capital LtdFull Year Results
Sopheon PLCFull Year Results
Strix Group PLCFull Year Results
TClarke PLCFull Year Results
Keywords Studios PLCFull Year Results
ECSC Group PLCFull Year Results
Telit Communications PLCFull Year Results
Bellway PLCHalf Year Results
Diploma PLCTrading Statement
Anglo Pacific Group PLCFull Year Results
Frontier IP Group PLCHalf Year Results
Pendragon PLCFull Year Results
Applied Graphene Materials PLCHalf Year Results
Kenmare Resources PLCFull Year Results
Thursday 25 March 
Allied Minds PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Biome Technologies PLCFull Year Results
Cineworld Group PLCFull Year Results
Compass Group PLCTrading Statement
CVS Group PLCHalf Year Results
EnQuest PLCFull Year Results
Equiniti Group PLCFull Year Results
Faron Pharmaceuticals OyFull Year Results
Funding Circle Holdings PLCFull Year Results
Genedrive PLCHalf Year Results
International Public Partnerships LtdFull Year Results
IQE PLCFull Year Results
Lamprell PLCFull Year Results
Learning Technologies Group PLCFull Year Results
Pebble Group PLCFull Year Results
Robinson PLCFull Year Results
S4 Capital PLCFull Year Results
Safestyle UK PLCFull Year Results
SIG PLCFull Year Results
Surgical Innovations Group PLCFull Year Results
United Utilities Group PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Feb 2019 10:09

Faron Pharmaceuticals shares surge on latest Clevegen data

(Sharecast News) - Shares in Faron Pharmaceuticals were surging on Thursday morning, after it announced an update on early observations on immunity and clinical response of MATINS patients after administration of its 'Clevegen' product.

Read more
13 Feb 2019 12:20

Faron Pharmaceuticals Encouraged By Clever-1 Antibody Study Result

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said new data supports the use of Clever-1 antibodies in re-activating an immune response to tumours.Shares in Faron were up

Read more
19 Dec 2018 11:07

Faron Pharmaceuticals pins some hope to YODA trial

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals issued interim results from its pharmacokinetic/dynamic 'YODA' study on Wednesday, examining various formulations of recombinant human interferon-beta (IFN-beta).

Read more
14 Dec 2018 15:57

Dosing begins in Faron's study of 'Clevegen' drug

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Friday that the first patient has successfully been dosed in the phase I/II MATINS study of Clevegen, its wholly-owned novel precision cancer immunotherapy drug.

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 10:13

Traumakine treatment optimal for particular subgroup, Faron finds

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has identified, by genetic testing, an "optimal subgroup" of acute respiratory distress syndrome (ARDS) patients for Traumakine treatment who showed a substantial reduction in mortality during the INTEREST trial, it announced on Wednesday.

Read more
5 Dec 2018 09:09

Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine

LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, with a certain genetic mutation, to be

Read more
3 Dec 2018 10:50

WINNERS & LOSERS SUMMARY: McColl's Retail Plunges After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 8.9%, Evraz, up 7.8%, up

Read more
3 Dec 2018 10:09

Faron Pharmaceuticals applies to begin Clevegen clinical trials

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that its clinical trial application to conduct a Phase I/II study with 'Clevegen', its wholly-owned novel precision cancer immunotherapy drug in development for the treatment of selected metastatic or inoperable tumours, has been approved by the Finnish Medicines Agency (FIMEA).

Read more
6 Nov 2018 16:29

DIRECTOR DEALINGS: Faron Divisional Chief Medical Officer Buys Shares

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biopharmaceutical company.In a transaction

Read more
22 Oct 2018 15:32

Faron Reports Corticosteroids Interference In Traumakine Trial

LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Monday that it has found evidence suggesting that corticosteroids used in parallel to its Traumakine treatment had a significant effect on a

Read more
17 Sep 2018 10:37

Faron Pharmaceuticals Submits Clinical Trial Application For Clevegen

LONDON (Alliance News) - Faron Pharmaceuticals Oy said Monday it has filed a clinical trial application for its cancer immunotherapy drug Clevegen.Clevegen, an anti-Clever-1 antibody, the a

Read more
13 Sep 2018 10:49

WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Royal Bank a

Read more
13 Sep 2018 10:30

Faron Pharmaceuticals Falls As Interim Loss Widens On Research Costs

LONDON (Alliance News) - Shares in Faron Pharmaceuticals Ltd dropped on Thursday after the company said its loss for the first half of its financial year increased on higher research were trading

Read more
13 Sep 2018 08:36

Faron losses widen following disappointing Traumakine trial

(Sharecast News) - Faron Pharmaceuticals' operating loss doubled in the first half of its trading year following the group's disappointing trial on its Traumakine treatment.

Read more
6789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.